Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/120816
Título: | CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3 | Autores/as: | Canada-Garcia, JE Moure, Z Sola-Campoy, PJ Delgado-Valverde, M Cano, ME Gijon, D Gonzalez, M Gracia-Ahufinger, I Larrosa, N Mulet, X Pitart, C Rivera, A Bou, G Calvo, J Canton, R Gonzalez-Lopez, JJ Martinez-Martinez, L Navarro, F Oliver Serra, Albert Palacios-Baena, ZR Pascual, A Ruiz-Carrascoso, G Vila, J Aracil, B Perez-Vazquez, M Oteo-Iglesias, J Pérez Arellano, José Luis GEMARA/GEIRAS-SEIMC/REIPI CARB-ES-19 Study Group |
Clasificación UNESCO: | 32 Ciencias médicas 320103 Microbiología clínica |
Palabras clave: | CARB-ES-19 study Carbapenemases Whole genome sequencing Klebsiella pneumoniae High-risk clones |
Fecha de publicación: | 2022 | Publicación seriada: | Frontiers in Microbiology | Resumen: | Objectives: CARB-ES-19 is a comprehensive, multicenter, nationwide study integrating whole-genome sequencing (WGS) in the surveillance of carbapenemase-producing K. pneumoniae (CP-Kpn) and E. coli (CP-Eco) to determine their incidence, geographical distribution, phylogeny, and resistance mechanisms in Spain. Methods: In total, 71 hospitals, representing all 50 Spanish provinces, collected the first 10 isolates per hospital (February to May 2019); CPE isolates were first identified according to EUCAST (meropenem MIC > 0.12 mg/L with immunochromatography, colorimetric tests, carbapenem inactivation, or carbapenem hydrolysis with MALDI-TOF). Prevalence and incidence were calculated according to population denominators. Antibiotic susceptibility testing was performed using the microdilution method (EUCAST). All 403 isolates collected were sequenced for high-resolution single-nucleotide polymorphism (SNP) typing, core genome multilocus sequence typing (cgMLST), and resistome analysis. Results: In total, 377 (93.5%) CP-Kpn and 26 (6.5%) CP-Eco isolates were collected from 62 (87.3%) hospitals in 46 (92%) provinces. CP-Kpn was more prevalent in the blood (5.8%, 50/853) than in the urine (1.4%, 201/14,464). The cumulative incidence for both CP-Kpn and CP-Eco was 0.05 per 100 admitted patients. The main carbapenemase genes identified in CP-Kpn were blaOXA–48 (263/377), blaKPC–3 (62/377), blaVIM–1 (28/377), and blaNDM–1 (12/377). All isolates were susceptible to at least two antibiotics. Interregional dissemination of eight high-risk CP-Kpn clones was detected, mainly ST307/OXA-48 (16.4%), ST11/OXA-48 (16.4%), and ST512-ST258/KPC (13.8%). ST512/KPC and ST15/OXA-48 were the most frequent bacteremia-causative clones. The average number of acquired resistance genes was higher in CP-Kpn (7.9) than in CP-Eco (5.5). Conclusion: This study serves as a first step toward WGS integration in the surveillance of carbapenemase-producing Enterobacterales in Spain. We detected important epidemiological changes, including increased CP-Kpn and CP-Eco prevalence and incidence compared to previous studies, wide interregional dissemination, and increased dissemination of high-risk clones, such as ST307/OXA-48 and ST512/KPC-3. | URI: | http://hdl.handle.net/10553/120816 | ISSN: | 1664-302X | DOI: | 10.3389/fmicb.2022.918362 | Fuente: | Frontiers in microbiology [ISSN 1664-302x], v. 13, 918362, (Junio 2022) |
Colección: | Artículos |
Citas SCOPUSTM
30
actualizado el 24-nov-2024
Citas de WEB OF SCIENCETM
Citations
28
actualizado el 24-nov-2024
Visitas
71
actualizado el 05-oct-2024
Descargas
22
actualizado el 05-oct-2024
Google ScholarTM
Verifica
Altmetric
Comparte
Exporta metadatos
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.